North America Peripheral Vascular Devices Market Size (2022 to 2027)
The North America Peripheral Vascular Devices Market was worth USD 3487.56 million in 2022 and is estimated to be growing at a CAGR of 7.27%, to reach USD 4953.51 million by 2027.
The diminishing incidences of coronary angioplasties and the expanding intervention techniques have affected the surgical equipment market, mainly in North America.
The risk of restenosis in angioplasty procedures energizes the selection of novel advancements to limit post-surgical complications. Among different surgical devices, bioabsorbable stents were observed to be a breakthrough in the market. The bioabsorbable stents market is relied upon to witness a huge CAGR of 62.2% during the forecast period. The achievement accomplished during the progressing studies is additionally expected to spur market adoption.
In addition to the next-generation stent, progressed diagnostic catheters, such as optical intelligence tomography (OCT) and intravascular ultrasound (IVUS) catheters, are required to develop faster in the coming years. Compared with conventional guiding catheters, a better diagnosis of vascular health is the reason behind the critical market development. In the market, the retrievable inferior vena cava filter (IVC) possesses a remarkable market space as it turns into the best quality level for the treatment of DVT/PE in North America. Also, diminished risk of long term post-surgical complication, which is regular with changeless IVC channels, is expected to ensure a CAGR of 14.8% during the forecast time period.
This research report on the North America Peripheral Vascular Devices Market has been segmented & sub-segmented into the following categories:
By Product Type:
- Stents
- Balloon-Expandable Stent
- Self-Expandable Stents
- Secured Stents
- Embolic Protection Devices
- Angioplasty Balloons
- Ordinary
- Cutting
- Scoring
- Medication
- Aortic Stent-Grafts
- Inferior Vena Cava Filters
- Synthetic Surgical Grafts
- Peripheral Vascular Accessory Devices
- Vascular Closure Devices
- Chronic Total Occlusion (CTO) Devices
- PTA Balloon Catheters
By Material:
- Resistant
- Semi-Consistent Sorts
By Country:
- The United States
- Canada
- Rest of North America
Based on geography, the Canadian Peripheral Vascular Devices Market still needs a sufficient number of cardiac facilities and skilled interventionists. Also, the normal waiting time for availing heart care is horrifying in Canada; such a variable is expected to fuel the adoption of advanced minimally obstructive strategies in Canada in the coming years.
The eminent players leading the North American Peripheral Vascular Devices market incorporate Abbott Laboratories (U.S.), Cordis Corporation (U.S.), Medtronic, Inc. (U.S.), Boston Scientific Corporation (U.S.), and Covidien, Inc. (U.S.).
- Introduction
- Market Definition
- Study Deliverables
- Base Currency, Base Year and Forecast Periods
- General Study Assumptions
- Research Methodology
- Introduction
- Research Phases
-
- Secondary Research
- Primary Research
- Econometric Modelling
- Expert Validation
- Analysis Design
- Study Timeline
- Overview
- Executive Summary
- Key Inferences
- New Developments
- Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
- Market Drivers
- Market Restraints
- Key Challenges
- Current Opportunities in the Market
- Market Segmentation
- Product type
- Introduction
- Normal balloon
- Cutting balloon
- Scoring Balloon
- Drug coated balloon
- Y-o-Y Growth Analysis, By Product type
- Market Attractiveness Analysis, By Product type
- Market Share Analysis, By Product type
- By Material
- Introduction
- Non-Compliant Balloons
- Semi-Compliant Balloons
- Y-o-Y Growth Analysis, By Material
- Market Attractiveness Analysis, By Material
- Market Share Analysis, By Material
- By Stents
- Introduction
- Balloon expandable stent
- Self-expandable stents
- Covered Stents
- Y-o-Y Growth Analysis, By Stents
- Market Attractiveness Analysis, By Stents
- Market Share Analysis, By Stents
- By Devices
- Introduction
- Angioplasty Balloons and Stents
- Catheters
- Hemodynamic Flow Alteration Devices
- Plaque Modification Devices
- Vena Cava Filter Placement Devices
- Mechanical Atherectomy Devices
- Accessory Devices
- Y-o-Y Growth Analysis, By Devices
- Market Attractiveness Analysis, By Devices
- Market Share Analysis, By Devices
- Geographical Analysis
- Introduction
- Regional Trends
- Impact Analysis
- Y-o-Y Growth Analysis
- By Geographical Area
- By Component Type
- By Form
- Market Attractiveness Analysis
- By Geographical Area
- By Component Type
- By Form
- Market Share Analysis
- By Geographical Area
- By Component Type
- By Form
- North America
- Introduction
- US
- Canada
- Europe
- Introduction
- UK
- France
- Spain
- Germany
- Italy
- Asia-Pacific
- Introduction
- India
- China
- Japan
- South Korea
- Australia
- Latin America
- Introduction
- Brazil
- Argentina
- Mexico
- Middle East & Africa
- Introduction
- Middle East
- Africa
- Strategic Analysis
- PESTLE analysis
- Political
- Economic
- Social
- Technological
- Legal
- Environmental
- Porter’s Five analysis
- Bargaining Power of Suppliers
- Bargaining Power of Consumers
- Threat of New Entrants
- Threat of Substitute Products and Services
- Competitive Rivalry within the Industry
- Market Leaders' Analysis
- Abbot Laboratories
- Overview
- Product Analysis
- Strategic Evaluation and Operations
- Financial analysis
- Legal issues
- Recent Developments
- SWOT analysis
- Analyst View
- Angioscore
- Boston Scientific Corporation
- Bayer AG
- Emboline INC
- Competitive Landscape
- Market share analysis
- Merger and Acquisition Analysis
- Agreements, Collaborations and Joint Ventures
- New Product Launches
- Market Outlook and Investment Opportunities
- Appendix
- List of Tables
- List of Figures